← Browse by Condition
Medical Condition

brain tumor adult

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for brain tumor adult sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain tumor adult Clinical Trials

How many clinical trials are currently recruiting for brain tumor adult?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for brain tumor adult, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for brain tumor adult?
brain tumor adult research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a brain tumor adult clinical trial?
Eligibility criteria for brain tumor adult trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Center Eugene Marquis 1 trial
Second Affiliated Hospital, Zhejiang University, School of Medicine 1 trial
Medical University of Warsaw 1 trial

Recruiting Clinical Trials

NCT07570485
Recruiting
Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor
Enrollment
90 pts
Location
France
Sponsor
Center Eugene Marquis
View Trial →
NCT07198256
Recruiting
AI-assisted Diagnosis of Malignant Brain Tumors
Enrollment
3,000 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
View Trial →
NCT07411690
Recruiting
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
Enrollment
200 pts
Location
Poland
Sponsor
Medical University of Warsaw
View Trial →

Related Conditions

gliomas (1) brain metastases adult (1) lymphoma (1) brain tumor benign (1) cerebrospinal fluid csf leak (1) craniotomy (1) glioblastoma (1) glioma (1) meningioma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology